Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party
Autor: | Sun-Hee Kim, Hyeon Seok Eom, Je-Jung Lee, Jong Youl Jin, Hyo Jung Kim, Kyung Sam Cho, Sung-Soo Yoon, Chang-Ki Min, Dong Soon Lee, Cheolwon Suh, Jin Seok Kim, Soo Mee Bang, Kihyun Kim, Jae Hoon Lee, Yoon Hwan Chang, Deog-Yeon Jo |
---|---|
Rok vydání: | 2010 |
Předmět: |
medicine.medical_specialty
Pediatrics Biomedical Research Disease History 21st Century hemic and lymphatic diseases Immunopathology Internal medicine Republic of Korea Humans Medicine Multiple myeloma Hematology business.industry Incidence Incidence (epidemiology) Disease Management Myeloid leukemia Cancer History 20th Century medicine.disease Lymphoma Immunology Multiple Myeloma business |
Zdroj: | International Journal of Hematology. 92:52-57 |
ISSN: | 1865-3774 0925-5710 |
DOI: | 10.1007/s12185-010-0617-6 |
Popis: | The incidence of multiple myeloma suggests an ethnic difference. Compared to Caucasians, who have an incidence rate of 3–5/100,000, Asians show much lower incidence rate compared to them, in the range of 0.5–3/100,000. In Korea, The very first case report of multiple myeloma was published in 1959 [1], and was followed by a few case reports until the 1970s. Since that time, the number of cases of multiple myeloma in Korea increased steadily, reaching 100 cases/year in 1990 [2] and 500 cases/year in 2000 [3], and it is still going up. Currently in Korea, 1,000 patients are estimated to be diagnosed with multiple myeloma, and 700 patients are assumed to die of this disease every year, and 4,000–5,000 patients are suffering from this disease [4]. The most updated, age-standardized, incidence rate of multiple myeloma in Korea is 1.4/100,000, and ranked as the third most common among the hematologic malignancies, only surpassed by non-Hodgkin’s lymphoma and acute myeloid leukemia [5]. Besides, the mortality from multiple myeloma |
Databáze: | OpenAIRE |
Externí odkaz: |